QQ客服 官方微博 反馈留言

	Is it necessary for all samples to quantify 25OHD(2) and 25OHD(3) using LC-MS/MS in clinical practice?
	Yu, Songlin; Zhang, Ruiping; Zhou, Weiyan; Cheng, Xinqi; Cheng, Qian; Xia, Liangyu; Xie, Shaowei; Yin, Yicong; Sun, Dandan; Su, Wei
	2018
卷号	56期号:2页码:273-277
关键词	25OHD(2) 25OHD(3) immunoassay liquid chromatography-tandem mass spectrometry vitamin D
ISSN号	1434-6621
DOI	10.1515/cclm-2017-0520
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6361223
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yu, Songlin,Zhang, Ruiping,Zhou, Weiyan,et al. Is it necessary for all samples to quantify 25OHD(2) and 25OHD(3) using LC-MS/MS in clinical practice?[J],2018,56(2):273-277.
APA	Yu, Songlin.,Zhang, Ruiping.,Zhou, Weiyan.,Cheng, Xinqi.,Cheng, Qian.,...&Qiu, Ling.(2018).Is it necessary for all samples to quantify 25OHD(2) and 25OHD(3) using LC-MS/MS in clinical practice?.,56(2),273-277.
MLA	Yu, Songlin,et al."Is it necessary for all samples to quantify 25OHD(2) and 25OHD(3) using LC-MS/MS in clinical practice?".56.2(2018):273-277.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。